Microfluidic-electrochemical sensor for continuously monitoring epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine
By using peroxide polypyrrole as an affinity element and potential regulation cleaning technology in microfluidic-electrochemical sensors, the pollution problem of electrochemical sensors continuously detecting in biological fluids is solved, and the stability and sensitivity of serotonin is achieved. and specific detection, suitable for a variety of biological samples.
Patent Information
- Application Number
- CN202411012639.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-26
- Publication Date
- 2024-11-12
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing electrochemical sensors are difficult to achieve continuous detection in biological fluids, and their contamination leads to limited large-scale applications and difficult to reuse.
Peroxide polypyrrole is used as a neurotransmitter affinity element, combined with potential regulation and cleaning technology, and a microfluidic-electrochemical sensor is constructed through electrochemical polymerization to achieve stable and continuous detection of serotonin.
Continuous monitoring of serotonin is achieved, with good sensitivity and specificity, and is suitable for detection in phosphate buffer, cell culture medium and healthy human plasma, and is successfully used for 5-HT level detection of human pancreatic cancer cells.
Smart Images

Figure CN118937432A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biosensor technology, and more specifically, relates to a microfluidic-electrochemical sensor for continuously monitoring the epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine. The constructed microfluidic-electrochemical sensor can be used in the fields of microfluidic chip systems, real-time monitoring of biomarkers in organoid chip platforms, etc. Background Art
[0002] Epilepsy is a common neurological disease. More than 70 million people suffer from epilepsy worldwide, including more than 9 million people in my country. The number of cases continues to increase at a rate of 600,000 cases per year, with an annual economic burden of more than 20 billion yuan. Epilepsy is characterized by repeated epileptic seizures caused by abnormal discharges of brain neurons, which can cause damage to different parts of the brain and trigger a series of neurological diseases such as depression, memory disorders, movement disorders, and neuroendocrine dysfunction. Sudden death in epilepsy is the main cause of premature death in epilepsy patients, especially those with refractory epilepsy. It is related to cardiac dysfunction, respiratory depression, and autonomic dysfunction during epileptic seizures. 5-hydroxytryptamine (5-HT), also known as serotonin, is an important neurotransmitter that plays a key role in epileptic seizures and sudden death in epilepsy. 5-HT also regulates sleep and wakefulness, and affects breathing and cardiac activity. Studies have shown that 5-HT depletion and transmission dysfunction may be an important mechanism of sudden death in epilepsy. Therefore, it is crucial to have a deeper understanding of the relationship between 5-HT and epileptic seizures, which will provide direction for the development of new epilepsy diagnosis and treatment methods. Early diagnosis and timely treatment of epilepsy and its cognitive dysfunction are of great significance to improving patient prognosis.
[0003] In recent years, with the continuous development of detection technology, a variety of emerging detection technologies have become possible for epilepsy diagnosis and prognosis. In vitro diagnosis is a service or technology that can quantitatively monitor changes in disease-related components from biological fluids directly related to human health to assist in individualized diagnosis and treatment. In vitro diagnosis has evolved from human plasma and urine to sweat, tears, interstitial fluid and other body fluids. Microfluidic chip-based detection technology is the mainstream technology of the new generation of in vitro diagnosis. It integrates multiple processes such as biological fluid sample collection, pretreatment, detection, signal readout and data transmission. It has the characteristics of automation, miniaturization and integration, and can realize the detection of marker content in a small amount of samples, such as blood and sweat. The main microfluidic chip signal readout technologies currently include colorimetry, fluorescence, electroluminescence, electrochemistry, etc. Among them, electrochemical sensing technology is one of the earliest detection technologies developed for neurochemical substances. Due to its low cost, simple structure, high selectivity, high sensitivity and good stability, it has attracted the attention of more and more researchers. Electrochemical sensors use electrochemical instruments as signal converters to connect the concentration changes of the measured components with electrical signals, and detect the information of the chemical components detected in the system in real time. Compared with other detection technologies, electrochemical sensing technology has the advantages of high sensitivity, fast response time, strong marker specificity, miniaturization and simple operation. The most promising advantage of electrochemical sensing technology in in vitro diagnosis is that they can be integrated into handheld devices, can be deployed at the clinical bedside or at home and community sites, and can be expanded to possible real-time analysis and large-scale management in the coming era. Despite this, the interface of electrochemical sensors is contaminated by biological fluids such as plasma and sweat, and its application in clinical sample detection is still subject to many restrictions. It is difficult to reuse it for multiple continuous tests, so its large-scale application is limited.
[0004] Therefore, the present invention proposes a microfluidic-electrochemical sensor for continuously monitoring the epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine, which utilizes electroactive neurotransmitter-affinity polypyrrole peroxide and potential-controlled cleaning technology to achieve low-cost microfluidic-electrochemical sensor preparation and continuous monitoring of 5-hydroxytryptamine in biological fluids. Summary of the invention
[0005] 1. The purpose of the present invention is to provide a microfluidic-electrochemical sensor for continuous monitoring of epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine.
[0006] 2. The microfluidic-electrochemical sensor for continuously monitoring the epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine described in the present invention uses polypyrrole peroxide as a neurotransmitter affinity element, and an acrylic plate is used to make a microfluidic device substrate through laser engraving technology to construct a low-cost microfluidic-electrochemical sensor.
[0007] 3. The microfluidic-electrochemical sensor for continuously monitoring the epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine described in the present invention is based on the basic principle of capacitive deionization and proposes an electrode interface cleaning technology based on potential regulation to achieve stable and continuous detection of the microfluidic-electrochemical sensor in biological fluids.
[0008] 4. The continuous detection of 5-HT by a microfluidic-electrochemical sensor for continuously monitoring the epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine described in the present invention includes detection in phosphate buffer, cell culture fluid and healthy human plasma.
[0009] 5. The method for manufacturing a microfluidic-electrochemical sensor for continuously monitoring the electroactive neurotransmitter 5-hydroxytryptamine related to epilepsy according to the present invention comprises the following steps in sequence:
[0010] (1) The screen printed electrode (SPCE) was simply cleaned with ultrapure water;
[0011] (2) constructing polypyrrole (PPY) coatings by electrochemical polymerization;
[0012] (3) Preparation of peroxidized polypyrrole (OPPY) coating by electrochemical scanning;
[0013] (4) Design and manufacture substrates for microfluidic devices;
[0014] (5) Assembling the screen-printed electrode modified with polypyrrole peroxide (OPPY / SPCE) with the microfluidic device substrate to fabricate a microfluidic-electrochemical sensor;
[0015] (6) Microfluidic-electrochemical sensor for detection of 5-HT in flowing liquid;
[0016] (7) After the detection, the detection surface of the microfluidic-electrochemical sensor is cleaned using a current-time potential control method, and then the microfluidic-electrochemical sensor is used for the next 5-HT detection.
[0017] 6. The application of a microfluidic-electrochemical sensor for continuous monitoring of the electroactive neurotransmitter 5-hydroxytryptamine related to epilepsy described in the present invention is to detect the level of 5-HT released by human pancreatic cancer cells (QGP-1) when stimulated by drugs, and evaluate the 5-HT detection performance of the constructed microfluidic-electrochemical sensor in a cell culture environment. The control model group is the 5-HT released by normal QGP-1 cells, and the drug intervention model group is the QGP-1 cells and the cell surface highly expressed transient receptor potential anchor protein 1 channel (TRPA1) agonist propyl isothiocyanate (AITC) or cinnamaldehyde (CA) after the stimulation enhances the release of 5-HT by QGP-1 cells. The microfluidic-electrochemical sensor is used to detect the level of 5-HT released by cells in the control model group and the propyl isothiocyanate (AITC) or cinnamaldehyde (CA) drug intervention group. The results showed that the two drug stimulation groups (AITC or CA) enhanced the level of 5-HT released from QGP-1 cells to varying degrees, and the hierarchical efficacy of TRPA1 agonists in stimulating 5-HT release was AITC>CA.
[0018] Specifically, the microfluidic-electrochemical sensor for continuously monitoring the epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine described in the present invention is characterized in that it is prepared by the following steps: (1) modifying the surface of the screen-printed electrode with polypyrrole peroxide by electrochemical polymerization and cyclic voltammetry to obtain a screen-printed electrode modified with polypyrrole peroxide; (2) using an acrylic plate to make a microfluidic device substrate by precise engraving; (3) using double-sided tape and photocurable resin to assemble the screen-printed electrode modified with polypyrrole peroxide obtained in step (1) with the microfluidic device substrate obtained in step (2) to prepare a microfluidic-electrochemical sensor; (4) under a flow system, using the prepared microfluidic-electrochemical sensor to detect the 5-hydroxytryptamine content by differential pulse voltammetry; (5) then cleaning the microfluidic-electrochemical sensor electrode by a potential control method for the next 5-hydroxytryptamine detection by the microfluidic-electrochemical sensor.
[0019] The microfluidic-electrochemical sensor for continuously monitoring the epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine is characterized in that the detection liquid suitable for detecting 5-hydroxytryptamine 5-HT includes phosphate buffer, human plasma and cell contact fluid, the 5-HT concentration range in phosphate buffer is 0.025μmol / L~10μmol / L, the 5-HT concentration range in 5wt% human plasma is 0.1μmol / L~10μmol / L, and the 5-HT concentration range in cell contact fluid is 0.05μmol / L~10μmol / L.
[0020] The microfluidic-electrochemical sensor for continuously monitoring the epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine is characterized in that, based on the basic principle of capacitive deionization, an electrode interface cleaning technology based on potential regulation is adopted to achieve stable and continuous monitoring of 5-HT in a fluid liquid by the microfluidic-electrochemical sensor.
[0021] The microfluidic-electrochemical sensor for continuously monitoring the epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine is characterized in that the entire process of liquid flow, signal detection and electrode cleaning in the microfluidic-electrochemical sensor is completely controlled by a peristaltic pump and an electrochemical workstation, and can stably and continuously monitor the neurotransmitter 5-hydroxytryptamine.
[0022] The method for manufacturing the microfluidic-electrochemical sensor for continuously monitoring the epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine of the present invention comprises the following steps in sequence:
[0023] (1) cleaning and pre-treating the screen-printed electrode SPCE with ultrapure water;
[0024] (2) constructing a polypyrrole (PPY) coating on the SPCE interface by electrochemical polymerization;
[0025] (3) Preparation of peroxidized polypyrrole (OPPY) coating on the SPCE interface by electrochemical oxidation;
[0026] (4) Design and manufacture microfluidic device substrates;
[0027] (5) Assembling the polypyrrole peroxide modified screen-printed electrode OPPY / SPCE with a microfluidic device substrate to fabricate a microfluidic-electrochemical sensor;
[0028] (6) Microfluidic-electrochemical sensor for detecting 5-hydroxytryptamine (5-HT) in flowing liquid;
[0029] (7) The sensing interface of the microfluidic-electrochemical sensor is cleaned by a potential control method, and then the microfluidic-electrochemical sensor is used for the next 5-HT detection.
[0030] The detection operation method of the microfluidic-electrochemical sensor for continuously monitoring the electroactive neurotransmitter 5-hydroxytryptamine related to epilepsy prepared by the manufacturing method of the microfluidic-electrochemical sensor for continuously monitoring the electroactive neurotransmitter 5-hydroxytryptamine related to epilepsy of the present invention is characterized by comprising the following specific steps:
[0031] (1) Cleaning of screen-printed electrode SPCE: Clean SPCE three times with ultrapure water to remove adsorbed substances on the electrode surface, dry with nitrogen gas and set aside;
[0032] (2) Preparation of polypyrrole modified screen-printed electrode PPY / SPCE: The SPCE cleaned in step (1) was immersed in an aqueous solution containing 10 mmol / L pyrrole and 10 mmol / L poly(sodium 4-styrene sulfonate), and scanned by cyclic voltammetry (CV) using a CHI660E electrochemical workstation, with a scanning potential of 0 to 0.8 V and a scanning rate of 5 mV / s for 5 cycles to obtain a polypyrrole modified screen-printed electrode PPY / SPCE, which was then washed with ultrapure water, dried with nitrogen gas, and set aside;
[0033] (3) Preparation of polypyrrole peroxide modified screen-printed electrode OPPY / SPCE: The OPPY / SPCE prepared in step (2) was immersed in a 0.5 mol / L NaOH solution, and the polypyrrole coating was peroxidized by the CV method, with a scanning potential of 0 to 1 V and a scanning rate of 10 mV / s for 12 cycles to obtain a polypyrrole peroxide modified screen-printed electrode OPPY / SPCE, which was then washed with ultrapure water and set aside;
[0034] (4) Preparation of microfluidic device substrate: Use WPS Office PowerPoint to draw the plane structure of the cover plate and the flow channel plate of the microfluidic device substrate. According to the drawn pattern, use a laser engraving machine to carve out a hollow part on the acrylic plate to obtain the microfluidic device substrate;
[0035] (5) Preparation of microfluidic-electrochemical sensor: The top surface of the flow channel of the microfluidic device substrate prepared in step (4) is adhered with a 0.2 mm thick PET transparent double-sided tape, and the double-sided tape at the liquid inlet and outlet is hollowed out, and the top surface is adhered to the cover plate, and the OPPY / SPCE prepared in step (3) is adhered to the detection area of the flow channel sheet with the OPPY modified interface facing the flow channel sheet, and the bottom surface is sealed with a 2 mm thick flexible strong tape, and the gap is filled with photocurable resin, and light-cured for 120 seconds under LED light to prepare a microfluidic-electrochemical sensor;
[0036] (6) Liquid flow system of microfluidic-electrochemical sensor: Use a rubber hose to connect the liquid inlet and liquid outlet of the microfluidic-electrochemical sensor prepared in step (5) to a peristaltic pump, and pump the test liquid into the microfluidic-electrochemical sensor at a flow rate of 50 μL / min to fill the microfluidic-electrochemical sensor;
[0037] (7) Electrochemical detection of microfluidic-electrochemical sensor in flow system: After the test liquid filled the test area, the peristaltic pump flow rate was maintained at 5 μL / min. After continuous operation for 20 min, 5-HT was detected using differential pulse voltammetry (DPV) using a CHI660E electrochemical workstation. The potential was -0.1 V to 0.6 V, the amplitude was 0.05 V, the pulse width was 0.05 s, the sampling width was 0.005 s, the pulse period was 0.2 s, and the DPV oxidation peak current value was recorded.
[0038] (8) Cleaning of the microfluidic-electrochemical sensor: After the detection in step (7) is completed, PBS is pumped into the microfluidic chip from the cleaning solution injection port at a flow rate of 50 μL / min to clean the electrochemical detection area of the microfluidic-electrochemical sensor; the PBS is kept flowing at a flow rate of 50 μL / min, and the electrode interface is cleaned by potential control, that is, a chronoamperometry scan is performed, the scanning potential is set to 0.4 V, and the scanning time is 50 s. After the scan is completed, the peristaltic pump flow rate is increased to 500 μL / min to clean the electrode interface, and then the peristaltic pump speed is reduced to 50 μL / min, and a second chronoamperometry scan is performed, the scanning voltage is set to -0.4 V, and the scanning time is 50 s. After the scan is completed, the liquid pumping from the cleaning solution injection port is stopped, and the microfluidic-electrochemical sensor cleaned by the potential control method is regenerated to achieve the regeneration of the electrode interface, and the above steps (6) and (7) are continued, and it can be used for the next 5-HT detection.
[0039] The invention discloses a method for preparing a microfluidic-electrochemical sensor for continuously monitoring the electroactive neurotransmitter 5-hydroxytryptamine related to epilepsy, and the application of the microfluidic-electrochemical sensor for continuously monitoring the electroactive neurotransmitter 5-hydroxytryptamine related to epilepsy is characterized in that: the level of 5-HT released by human pancreatic cancer cells QGP-1 when stimulated by drugs is detected, and the 5-HT detection performance of the constructed microfluidic-electrochemical sensor in a cell culture environment is evaluated; the control model group is the 5-HT released by normal QGP-1 cells, and the drug intervention model group is the QGP-1 cells and the transient receptor potential anchoring protein 1 highly expressed on the cell surface are passed through The TRPA1 agonists AITC or CA stimulated and enhanced the release of 5-HT from QGP-1 cells. Microfluidic-electrochemical sensors were used to detect the levels of 5-HT released by cells in the control model group and AITC or CA drug intervention groups. The results showed that AITC or CA in the two drug stimulation groups enhanced the levels of 5-HT released from QGP-1 cells to varying degrees, and the hierarchical efficacy of TRPA1 agonists in stimulating 5-HT release was AITC>CA. The above results all prove that microfluidic-electrochemical sensors can be used for the detection of epilepsy-related electroactive neurotransmitter 5-HT.
[0040] Advantages of the present invention: The present invention proposes a microfluidic-electrochemical sensor for continuous monitoring of the epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine, which realizes stable and continuous detection of 5-HT through neurotransmitter affinity interface and potential-controlled cleaning, and the microfluidic-electrochemical sensor has good sensitivity and specificity, and realizes continuous detection of 5-HT in a variety of flowing liquids such as phosphate buffer, cell culture fluid and healthy human plasma, and is successfully used for the detection of 5-HT levels released by human pancreatic cancer cells when stimulated by drugs. This method can provide a research basis for the research on the detection method of epilepsy-related neurotransmitter 5-HT and other electroactive neurotransmitters, and is expected to be used in the fields of microfluidic system scale-up, real-time monitoring research of biomarkers on organoid chip platforms, etc. BRIEF DESCRIPTION OF THE DRAWINGS
[0041] Figure 1 The present invention is a schematic diagram of the preparation and detection of a microfluidic-electrochemical sensor for continuous monitoring of the epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine.
[0042] Figure 2 The Fourier transform infrared spectroscopy characterization results of PPY and OPPY are shown in Figure 1. In the infrared spectrum, ~3500cm -1 The absorption peak of OPPY corresponding to the stretching vibration of hydroxyl is more obvious than that of PPY. This is the result of over-oxidation, indicating that more carboxyl groups and hydroxyl groups are generated on the surface of OPPY.
[0043] Figure 3 These are the scanning electron microscopy characterization results of SPCE, PPY / SPCE, and OPPY / SPCE. Figure 3 Middle A and Figure 3 (B) The SPCE surface shows a large number of aggregated carbon particles and graphite flakes of different sizes. Figure 3 Middle C and Figure 3 D in the middle shows that the PPY / SPCE surface exhibits denser spherical particles and porous structure than the SPCE surface, indicating that pyrrole was successfully prepared on the SPCE surface. Figure 3 ZhongE and Figure 3 Figure F shows that under peroxidation conditions, the compact structure of the PPY backbone changes, the surface structure of OPPY / SPCE becomes looser and more uniform, and the particles and pore structures become more miniaturized.
[0044] Figure 4 Electrochemical impedance spectroscopy (EIS) of SPCE, PPY / SPCE, and OPPY / SPCE. Figure 4Curve a in the figure is OPPY / SPCE, curve b is SPCE, and curve c is PPY / SPCE. The impedance curve of PPY / SPCE shows that it has the largest resistance. This is because poly(sodium 4-styrenesulfonate) (PSS) is used as the dopant. The steric hindrance of the sulfonic acid group is large. After it is doped into PPY, it is fixed in the PPY film. PSS is an insulator, so it has a larger impedance than bare SPCE. When the PPY modified electrode is subjected to the next step of peroxidation treatment to form an OPPY interface, the electrode surface is dedoped to form a more stable porous polypyrrole film with high conductivity.
[0045] Figure 5 These are the differential pulse voltammetry (DPV) test results of blank PBS solution and PBS solution containing 10 μmol / L 5-HT and 10 μmol / L dopamine (DA). Figure 5 The DPV results of 10 μmol / L 5-HT and 10 μmol / L DA in the medium showed significant differences from the detection electrical signals of the blank PBS solution at around 0.1V and 0.3V, indicating that the sensor can be used for the simultaneous detection of 5-HT and DA.
[0046] Figure 6 The cyclic voltammetry (CV) spectrum of 10 μmol / L 5-HT at a scan rate of 10 mV / s to 100 mV / s and the corresponding relationship between peak current and scan rate are shown. Figure 6 Figure A shows that the electrocatalytic properties of the sensor to 5-HT were studied by CV method at different scan rates in 10 μmol / L 5-HT. A clear oxidation peak was obtained on OPPY / SPCE. The peak potential shifted in the high potential direction with the increase of scan rate, but the peak current increased significantly with the increase of scan rate. Figure 6 B in the middle is a summary of all the relationships between scan rate and peak current to obtain a fitting straight line, indicating that the advantage of OPPY / SPCE as a 5-HT sensor comes from the adsorption and accumulation characteristics of 5-HT, indicating that there is an adsorption-controlled electron transfer mechanism for 5-HT in OPPY / SPCE.
[0047] Figure 7 The DPV detection diagram of 10 μmol / L 5-HT by the microfluidic-electrochemical sensor in buffer solutions with different pH values (A) and the relationship between pH and 5-HT detection current response (B). Figure 7 A in the figure shows that the response potential of the microfluidic-electrochemical sensor to 5-HT decreases with increasing pH, while the response current shows a trend of first increasing and then decreasing. The highest current response to 10 μmol / L 5-HT was obtained under the condition of buffer pH 7.0 (see Figure 7B), and the pH value is close to the pH value of the physiological environment in the human body, so the buffer solution pH is 7.0 for subsequent experiments.
[0048] Figure 8 A graph showing the specificity test results of the microfluidic-electrochemical sensor for different interferents and 5-HT. Figure 8 The specificity investigation results of the microfluidic-electrochemical sensor show that the current response signal value generated in 5μmol / L ascorbic acid, urea, uric acid, glucose, and tryptophan solutions is negligible compared with the current response signal value of 500nmol / L 5-HT detection. The current response value of 500nmol / L 5-HT is not affected when the above interfering substances are present. This result shows that the microfluidic-electrochemical sensor of the present invention has good specificity for 5-HT detection.
[0049] Fig. 9 This is a graph showing the result of four consecutive 5-HT repeated detection responses to electrical signals based on a simple washing method. Fig. 9 A in the figure adopts a simple cleaning method, that is, after performing a DPV scan on 500nmol / L 5-HT in the microfluidic-electrochemical sensor, it is washed with PBS and then the next DPV test of 5-HT is performed. This cleaning process will produce a gradually attenuated response signal during the repeated 5-HT detection process of the electrode. Fig. 9 Figure B shows the peak current values recorded for four DPV tests. After three uses, the 5-HT response current signal value detected by the microfluidic-electrochemical sensor decreased from 0.6 μA in the first test to 0.4 μA, indicating that the contaminated microfluidic-electrochemical sensor would reduce the sensitivity of the electrode.
[0050] Fig.10 This is a graph showing the results of seven consecutive 5-HT or DA repeated detections based on the potential-controlled washing method. Fig.10 Figure A shows that the electrode surface was cleaned using the potential control method and used for continuous detection of 5-HT. The microfluidic-electrochemical sensor detected 500nmol / L 5-HT seven times in a row, maintaining good reproducibility of the detected electrical signal value, and the DPV detection results were almost completely overlapped. Fig.10 B in the middle shows the peak current values recorded for 7 DPV tests, and the peak currents for the 7 tests hardly changed. Fig.10 Figure C shows that the electrode surface was cleaned by potential control method and used for continuous DA detection. The microfluidic-electrochemical sensor detected 500nmol / L DA for 7 consecutive times. The results showed that the detection response electrical signal maintained good reproducibility and the DPV detection results were almost completely overlapped. Fig.10D in the middle is the peak current value recorded for 7 DPV tests, and the peak current for 7 tests hardly changes. The results show that the potential control method of the present invention can remove the contamination of the microfluidic-electrochemical sensor by the electroactive neurotransmitter 5-HT or DA and realize continuous detection.
[0051] Fig.11 The response current of the microfluidic-electrochemical sensor to the concentration gradient of 5-HT or DA in PBS and the corresponding current-concentration relationship diagram. Fig.11 Figure A shows that the current response value of 5-HT detection by the microfluidic-electrochemical sensor in PBS is positively correlated with the concentration. Fig.11 B shows that the response current value shows a good linear relationship with the 5-HT concentration in the range of 0.025 μmol / L to 10 μmol / L, and the linear equation is I 5-HT (μA)=0.85C 5-HT (μmol / L)+0.012. Fig.11 (C) shows that the current response value of the microfluidic-electrochemical sensor in PBS is positively correlated with the DA concentration. Fig.11 D in the figure shows a good linear relationship between the response current and the DA concentration in the range of 0.05 μmol / L to 10 μmol / L. DA (μA)=0.63C DA (μmol / L)+0.020. Fig.11 (E) The current response of the microfluidic-electrochemical sensor in PBS is positively correlated with the concentrations of 5-HT and DA when they are present simultaneously. Fig.11 F in the middle shows a good linear relationship between the response current value and the 5-HT concentration in the range of 0.05μmol / L to 10μmol / L, and the linear equation is I 5-HT (μA)=0.59C 5-HT (μmol / L)+0.013, the response current value and DA concentration show a good linear relationship in the range of 0.05μmol / L~10μmol / L, and the linear equation is I DA (μA)=0.31C DA (μmol / L) + 0.047. This result indicates that the microfluidic-electrochemical sensor of the present invention is suitable for detecting the electroactive neurotransmitter 5-HT or DA in PBS solution.
[0052] Fig.12 The response current of the microfluidic-electrochemical sensor to the concentration gradient of 5-HT or DA in 5% human plasma and the corresponding current-concentration relationship diagram. Fig.12 A in the figure shows that the current response value of the microfluidic-electrochemical sensor for 5-HT detection in 5% human plasma is positively correlated with the concentration. Fig.12The response current value in B shows a good linear relationship with the 5-HT concentration in the range of 0.1 μmol / L to 10 μmol / L, and the linear equation is I (μA) = 0.60C 5-HT (μmol / L)+0.77. Fig.12 (C) shows that the current response of the microfluidic-electrochemical sensor in PBS is positively correlated with the DA concentration. Fig.12 D in the middle is the response current value and DA concentration shows a good linear relationship in the range of 0.1μmol / L to 10μmol / L, I (μA) = 0.43C DA (μmol / L)-0.023. This result indicates that the microfluidic-electrochemical sensor of the present invention is suitable for the detection of electroactive neurotransmitters 5-HT or DA in 5% human plasma.
[0053] Fig.13 The response current of the microfluidic-electrochemical sensor to the concentration gradient of 5-HT or DA in the cell contact solution and the corresponding current-concentration relationship diagram. Fig.13 A in the middle shows that the current response value of the microfluidic-electrochemical sensor in the cell contact fluid is positively correlated with the 5-HT concentration. Fig.13 The response current value in B shows a good linear relationship with the 5-HT concentration in the range of 0.05 μmol / L to 10 μmol / L, and the linear equation is I (μA) = 0.71C 5-HT (μmol / L)+0.24. Fig.13 (C) shows that the current response value of the microfluidic-electrochemical sensor in PBS is positively correlated with the DA concentration. Fig.13 D in the middle is the response current value and DA concentration shows a good linear relationship in the range of 0.05μmol / L to 10μmol / L, I (μA) = 0.52C DA (μmol / L) + 0.047. This result indicates that the microfluidic-electrochemical sensor of the present invention is suitable for detecting the electroactive neurotransmitter 5-HT or DA in the cell contact fluid.
[0054] Fig.14 Schematic diagram of the functional areas (A) and assembly (B) of the microfluidic device. Fig.14 Figure A in the middle shows the microfluidic device. The two inlets on the left side are the test liquid inlet and the cleaning liquid inlet, which are used for detection and cleaning processes. A small circular area is designed between the flow channel and the detection area to collect the gas flowing into the device from the peristaltic pump during the detection process, preventing the gas from entering the detection area and interfering with the detection results. The detection area is coupled with OPPY / SPCE for the detection of 5-HT in the test liquid. The right side is the waste liquid outlet for the outflow of the test liquid.
[0055] Fig.15 This is a physical picture of the microfluidic-electrochemical sensor.
[0056] Fig.16 To monitor the signal graph of different concentrations of 5-HT in the flow system, the concentration of 5-HT is 10, 25, 50, 100, and 500 nmol / L. Fig.16 Taking into account the slow flow time factor of the actual microfluidic system, the detection time interval was increased to 30 min, and the electrochemical sensor was cleaned once by potential control method in the microfluidic device after each measurement, and then a new solution was flowed into the microfluidic-electrochemical sensor. Aj was 10, 25, 50, 100, 500, 500, 100, 50, 25, and 10 nmol / L 5-HT, respectively. The results showed that the response current changed synchronously with the 5-HT concentration, and the current values detected for the same concentration of 5-HT were very similar, indicating that the method of the present invention can realize multiple and stable repeated detection of 5-HT in the microfluidic-electrochemical sensor.
[0057] Fig.17 Figure 2 shows the DPV detection results (A) of QGP-1 cells after allyl isothiocyanate (AITC) and cinnamaldehyde (CA) stimulated the release of 5-HT and the comparison of 5-HT secretion levels of cells (B). Fig.17 Figure A shows the DPV test results of 5-HT secretion by QGP-1 cells stimulated by 0.3mmol / L AITC or 0.3mmol / L CA, and the control group is the DPV test diagram of cell supernatant (containing 0.3% DMSO) without stimulation drugs. The results show that the two drug stimulation groups (AITC or CA) enhanced the level of 5-HT released by QGP-1 cells to varying degrees (see Fig.17 In B), the TRPA1 agonist stimulates 5-HT release in a hierarchical order of AITC > CA. 2+ Increased influx is considered to be one of the main pathways for enterochromaffin cells to release 5-HT. Agonists induce the release of 5-HT and Ca 2+ influx, while AITC and CA induce Ca 2+ In addition, studies have shown that 95% of the body's 5-HT is generated and released in the intestine, and then directly affects the balance of central neurotransmitters through the blood-brain barrier, or indirectly affects the central nervous system through the gut-brain axis, thereby causing neurological diseases such as epilepsy. Therefore, the microfluidic-electrochemical sensor constructed by the present invention detects the level of intestinal 5-HT release, which is helpful to predict epileptic seizures and monitor the progression of epilepsy. DETAILED DESCRIPTION
[0058] In order to make the technical problem, technical solution and effect to be solved by the present invention clearer, the present invention is further described in detail below in conjunction with embodiments and drawings.
[0059] The microfluidic-electrochemical sensor for continuously monitoring the epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine according to the present invention operates as follows:
[0060] (1) Preparation of testing instruments, reagents and solutions;
[0061] The instruments and equipment used in this invention were purchased from the following companies:
[0062]
[0063]
[0064] The reagents used in this invention are from the following companies:
[0065]
[0066] All reagents were prepared according to the following formula:
[0067] ① Aqueous solution containing 10 mmol / L pyrrole and 10 mmol / L poly(sodium 4-styrene sulfonate) (PSS): Accurately weigh 0.0206 g of PSS and dissolve it in 10 mL of ultrapure water. Add 7 μL of pyrrole and mix well. Store at 4°C away from light.
[0068] ②0.5mol / L NaOH solution: Accurately weigh 0.2000g NaOH and dissolve it in 10mL ultrapure water.
[0069] ③0.2 mol / L phosphate buffer stock solution: Accurately weigh 2.9642 g NaH2PO4·2H2O and 11.4988 g Na2HPO4 and dissolve them in 500 mL ultrapure water. Adjust the pH to 7.4 with NaOH solution to obtain PB buffer and store at 4°C.
[0070] ④ Phosphate buffer (PB): dilute 20 mL of 0.2 mol / L PB in 380 mL of ultrapure water, add 2.3376 g of NaCl and dissolve, and store at 4°C.
[0071] (2) Cleaning of screen-printed electrodes (SPCE): The SPCE was cleaned three times with ultrapure water to remove adsorbed substances on the electrode surface, and then dried with nitrogen for subsequent modification;
[0072] (3) Preparation of polypyrrole modified screen-printed electrode (PPY / SPCE): The SPCE cleaned in step (2) was immersed in an aqueous solution containing 10 mmol / L pyrrole and 10 mmol / L poly(sodium 4-styrene sulfonate), and the electrode was connected to a CHI660E electrochemical workstation. Cyclic voltammetry (CV) was used for scanning at a scan rate of 5 mV / s from 0 to 0.8 V for 5 cycles to obtain a polypyrrole modified screen-printed electrode (PPY / SPCE), which was then washed with ultrapure water and dried with nitrogen gas.
[0073] (4) Preparation of polypyrrole peroxide modified screen-printed electrode (OPPY / SPCE): The OPPY / SPCE prepared in step (3) was immersed in a NaOH solution with a concentration of 0.5 mol / L, and subjected to peroxidation treatment by CV method, and cycled 12 times from 0 to 1 V at a scanning rate of 10 mV / s to obtain a polypyrrole peroxide modified screen-printed electrode (OPPY / SPCE).
[0074] (5) Preparation of microfluidic device substrate: Use WPS Office PowerPoint to draw the planar structure of the cover plate and flow channel of the microfluidic substrate, and use a laser engraving machine to carve out a hollow part on the acrylic plate according to the drawn pattern to obtain the substrate of the microfluidic device;
[0075] (6) Preparation of microfluidic-electrochemical sensor: The top surface of the flow channel sheet of the microfluidic device obtained in step (5) is adhered with a 0.2 mm thick PET transparent double-sided tape, and the double-sided tape at the liquid inlet and outlet is hollowed out, and the top surface is adhered to the cover plate. The OPPY / SPCE obtained in step (4) is adhered to the detection area of the flow channel sheet with the OPPY modified surface facing the flow channel sheet, and the bottom surface is sealed with a 2 mm thick flexible strong tape. A small amount of photocurable resin is filled in the gap, and the photocuring is carried out under LED light for 120 seconds to prepare a complete microfluidic-electrochemical sensor.
[0076] (7) Liquid circulation of microfluidic-electrochemical sensor: Use rubber tubes to connect the liquid inlet and outlet of the microfluidic-electrochemical sensor prepared in step (6) to a peristaltic pump, and pump the test liquid into the microfluidic-electrochemical sensor at a flow rate of 50 μL / min to fill the sensor.
[0077] (8) Electrochemical detection of microfluidic-electrochemical sensor during liquid circulation: After the test liquid filled the detection area of the microfluidic-electrochemical sensor, the peristaltic pump flow rate was maintained at 50 μL / min. After the peristaltic pump ran for 20 min, the microfluidic-electrochemical sensor electrode was detected using differential pulse voltammetry (DPV) on the CHI660E electrochemical workstation interface. The potential was -0.1 V to 0.6 V, the amplitude was 0.05 V, the pulse width was 0.05 s, the sampling width was 0.005 s, the pulse period was 0.2 s, and the oxidation peak current value was recorded.
[0078] (9) Cleaning of the microfluidic-electrochemical sensor: After the detection in step (8) is completed, phosphate buffer (PB) is introduced into the microfluidic-electrochemical sensor at a flow rate of 50 μL / min through a peristaltic pump to ensure that all samples containing the analyte are rinsed clean. The time-current (it) method is used in the flowing PB solution with a scanning voltage of 0.4 V and a scanning time of 60 s. After that, the PB solution is kept flowing for 60 s to clean the electrode surface. The scanning voltage of the it method program is set to -0.4 V and the scanning time is 100 s. The electrode is cleaned again. After the end, the electrode surface is cleaned with flowing PB solution to achieve electrode regeneration. The detection of steps (7) and (8) is repeated.
[0079] The microfluidic-electrochemical sensor prepared in the present invention is shown in 1. Figure 1 The present invention is a schematic diagram of the preparation and detection of a microfluidic-electrochemical sensor for continuous monitoring of the epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine.
[0080] Figure 2 The Fourier transform infrared spectrum characterization result diagram of PPY and OPPY of the present invention. In the infrared spectrum, ~3500cm -1 The absorption peak of OPPY corresponding to the stretching vibration of hydroxyl is more obvious than that of PPY. This is the result of over-oxidation, indicating that more carboxyl groups and hydroxyl groups are generated on the surface of OPPY.
[0081] Figure 3 These are scanning electron microscope characterization results of SPCE, PPY / SPCE, and OPPY / SPCE of the present invention. Figure 3 Middle A and Figure 3 (B) The SPCE surface shows a large number of aggregated carbon particles and graphite flakes of different sizes. Figure 3 Middle C and Figure 3 D in the middle shows that the PPY / SPCE surface exhibits denser spherical particles and porous structure than the SPCE surface, indicating that pyrrole was successfully prepared on the SPCE surface. Figure 3 ZhongE and Figure 3Figure F shows that under peroxidation conditions, the compact structure of the PPY backbone changes, the surface structure of OPPY / SPCE becomes looser and more uniform, and the particles and pore structures become more miniaturized.
[0082] Figure 4 These are the electrochemical impedance spectroscopy (EIS) graphs of the SPCE, PPY / SPCE, and OPPY / SPCE of the present invention. Figure 4 Curve a in the figure is OPPY / SPCE, curve b is SPCE, and curve c is PPY / SPCE. The impedance curve of PPY / SPCE shows that it has the largest resistance. This is because poly(sodium 4-styrenesulfonate) (PSS) is used as the dopant. The steric hindrance of the sulfonic acid group is large. After it is doped into PPY, it is fixed in the PPY film. PSS is an insulator, so it has a larger impedance than bare SPCE. When the PPY modified electrode is subjected to the next step of peroxidation treatment to form an OPPY interface, the electrode surface is dedoped to form a more stable porous polypyrrole film with high conductivity.
[0083] Figure 5 The differential pulse voltammetry (DPV) test results of the blank PBS solution of the present invention and the PBS solution containing 10 μmol / L 5-HT and 10 μmol / L dopamine (DA) are shown. Figure 5 The DPV results of 10 μmol / L 5-HT and 10 μmol / L DA in the medium showed significant differences from the detection electrical signals of the blank PBS solution at around 0.1V and 0.3V, indicating that the sensor can be used for the simultaneous detection of 5-HT and DA.
[0084] Figure 6 The cyclic voltammetry (CV) spectrum of 10 μmol / L 5-HT at a scan rate of 10 mV / s to 100 mV / s and the corresponding relationship diagram between peak current and scan rate are shown in the present invention. Figure 6 Figure A shows that the electrocatalytic properties of the sensor to 5-HT were studied by CV method at different scan rates in 10 μmol / L 5-HT. A clear oxidation peak was obtained on OPPY / SPCE. The peak potential shifted in the high potential direction with the increase of scan rate, but the peak current increased significantly with the increase of scan rate. Figure 6 B in the middle is a summary of all the relationships between scan rate and peak current to obtain a fitting straight line, indicating that the advantage of OPPY / SPCE as a 5-HT sensor comes from the adsorption and accumulation characteristics of 5-HT, indicating that there is an adsorption-controlled electron transfer mechanism for 5-HT in OPPY / SPCE.
[0085] Figure 710 μmol / L 5-HT DPV detection diagram (A) of the microfluidic-electrochemical sensor of the present invention in buffer solutions of different pH values and a relationship diagram between pH and 5-HT detection current response (B). Figure 7 A in the figure shows that the response potential of the microfluidic-electrochemical sensor to 5-HT decreases with increasing pH, while the response current shows a trend of first increasing and then decreasing. The highest current response to 10 μmol / L 5-HT was obtained under the condition of buffer pH 7.0 (see Figure 7 B), and the pH value is close to the pH value of the physiological environment in the human body, so the buffer solution pH is selected as 7.0 for subsequent experiments.
[0086] Figure 8 This is a graph showing the specificity test results of the microfluidic-electrochemical sensor of the present invention for different interferents and 5-HT. Figure 8 The results of the specificity investigation of the microfluidic-electrochemical sensor show that the current response signal value generated in 5 μmol / L ascorbic acid, urea, uric acid, glucose, and tryptophan solutions is negligible compared with the current response signal value of 500nmol / L 5-HT detection. The current response value of 500nmol / L 5-HT is not affected when the above interfering substances are present. This result shows that the microfluidic-electrochemical sensor of the present invention has good specificity for 5-HT detection.
[0087] Fig. 9 This is a graph showing the result of four consecutive 5-HT repeated detection response electrical signal values based on the simple washing method of the present invention. Fig. 9 A in the figure adopts a simple cleaning method, that is, after performing a DPV scan on 500nmol / L 5-HT in the microfluidic-electrochemical sensor, it is washed with PBS and then the next DPV test of 5-HT is performed. This cleaning process will produce a gradually attenuated response signal during the repeated 5-HT detection process of the electrode. Fig. 9 Figure B shows the peak current values recorded for four DPV tests. After three uses, the 5-HT response current signal value detected by the microfluidic-electrochemical sensor decreased from 0.6 μA in the first test to 0.4 μA, indicating that the contaminated microfluidic-electrochemical sensor would reduce the sensitivity of the electrode.
[0088] Fig.10 This is a graph showing the results of seven consecutive 5-HT or DA repeated detections based on the potential-controlled cleaning method of the present invention. Fig.10 Figure A shows that the electrode surface was cleaned using the potential control method and used for continuous detection of 5-HT. The microfluidic-electrochemical sensor detected 500nmol / L 5-HT seven times in a row, maintaining good reproducibility of the detected electrical signal value, and the DPV detection results were almost completely overlapped. Fig.10Figure B shows the peak current values of 7 DPV tests. The peak currents of the 7 tests hardly changed. Fig.10 Figure C shows that the electrode surface was cleaned by potential control method and used for continuous DA detection. The microfluidic-electrochemical sensor detected 500nmol / L DA for 7 consecutive times. The results showed that the detection response electrical signal maintained good reproducibility and the DPV detection results were almost completely overlapped. Fig.10 D in the middle is the peak current value recorded for 7 DPV tests, and the peak current for 7 tests hardly changes. The results show that the potential control method of the present invention can remove the contamination of the microfluidic-electrochemical sensor by the electroactive neurotransmitter 5-HT or DA and realize continuous detection.
[0089] Fig.11 The microfluidic-electrochemical sensor of the present invention responds to the concentration gradient of 5-HT or DA in PBS and the corresponding current-concentration relationship diagram. Fig.11 Figure A shows that the current response value of 5-HT detection by the microfluidic-electrochemical sensor in PBS is positively correlated with the concentration. Fig.11 B shows that the response current value shows a good linear relationship with the 5-HT concentration in the range of 0.025 μmol / L to 10 μmol / L, and the linear equation is I 5-HT (μA)=0.85C 5-HT (μmol / L)+0.012. Fig.11 (C) shows that the current response value of the microfluidic-electrochemical sensor in PBS is positively correlated with the DA concentration. Fig.11 D in the figure shows a good linear relationship between the response current and the DA concentration in the range of 0.05 μmol / L to 10 μmol / L. DA (μA)=0.63C DA (μmol / L)+0.020. Fig.11 (E) The current response of the microfluidic-electrochemical sensor in PBS is positively correlated with the concentrations of 5-HT and DA when they are present simultaneously. Fig.11 F in the middle shows a good linear relationship between the response current value and the 5-HT concentration in the range of 0.05μmol / L to 10μmol / L, and the linear equation is I 5-HT (μA)=0.59C 5-HT (μmol / L)+0.013, the response current value and DA concentration show a good linear relationship in the range of 0.05μmol / L~10μmol / L, and the linear equation is I DA (μA)=0.31C DA (μmol / L) + 0.047. This result indicates that the microfluidic-electrochemical sensor of the present invention is suitable for detecting the electroactive neurotransmitter 5-HT or DA in PBS solution.
[0090] Fig.12 The diagram shows the response current of the microfluidic-electrochemical sensor of the present invention to the detection of 5-HT or DA with a concentration gradient in 5% human plasma and the corresponding current-concentration relationship diagram. Fig.12 A in the figure shows that the current response value of the microfluidic-electrochemical sensor for 5-HT detection in 5% human plasma is positively correlated with the concentration. Fig.12 The response current value in B shows a good linear relationship with the 5-HT concentration in the range of 0.1 μmol / L to 10 μmol / L, and the linear equation is I (μA) = 0.60C 5-HT (μmol / L)+0.77. Fig.12 (C) shows that the current response of the microfluidic-electrochemical sensor in PBS is positively correlated with the DA concentration. Fig.12 D in the middle is the response current value and DA concentration shows a good linear relationship in the range of 0.1μmol / L to 10μmol / L, I (μA) = 0.43C DA (μmol / L)-0.023. This result indicates that the microfluidic-electrochemical sensor of the present invention is suitable for the detection of electroactive neurotransmitters 5-HT or DA in 5% human plasma.
[0091] Fig.13 The diagram shows the response current of the microfluidic-electrochemical sensor of the present invention to the detection of 5-HT or DA with a concentration gradient in a cell contact solution and the corresponding current-concentration relationship diagram. Fig.13 A in the middle shows that the current response value of the microfluidic-electrochemical sensor in the cell contact fluid is positively correlated with the 5-HT concentration. Fig.13 The response current value in B shows a good linear relationship with the 5-HT concentration in the range of 0.05 μmol / L to 10 μmol / L, and the linear equation is I (μA) = 0.71C 5-HT (μmol / L)+0.24. Fig.13 (C) shows that the current response value of the microfluidic-electrochemical sensor in PBS is positively correlated with the DA concentration. Fig.13 D in the middle is the response current value and DA concentration shows a good linear relationship in the range of 0.05μmol / L to 10μmol / L, I (μA) = 0.52C DA (μmol / L) + 0.047. This result indicates that the microfluidic-electrochemical sensor of the present invention is suitable for detecting the electroactive neurotransmitter 5-HT or DA in the cell contact fluid.
[0092] Fig.14 Schematic diagram of the functional areas (A) and assembly (B) of the microfluidic device of the present invention. Fig.14Figure A in the middle shows the microfluidic device. The two inlets on the left side are the test liquid inlet and the cleaning liquid inlet, which are used for detection and cleaning processes. A small circular area is designed between the flow channel and the detection area to collect the gas flowing into the device from the peristaltic pump during the detection process, preventing the gas from entering the detection area and interfering with the detection results. The detection area is coupled with OPPY / SPCE for the detection of 5-HT in the test liquid. The right side is the waste liquid outlet for the outflow of the test liquid.
[0093] Fig.15 This is a physical picture of the microfluidic-electrochemical sensor of the present invention.
[0094] Fig.16 This is a signal diagram of monitoring different concentrations of 5-HT in a flow system according to the present invention, and the 5-HT concentrations are 10, 25, 50, 100, and 500 nmol / L. Fig.16 Taking into account the slow flow time factor of the actual microfluidic system, the detection time interval was increased to 30 min, and the electrochemical sensor was cleaned once by potential control method in the microfluidic device after each measurement, and then a new solution was flowed into the microfluidic-electrochemical sensor. Aj was 10, 25, 50, 100, 500, 500, 100, 50, 25, and 10 nmol / L 5-HT, respectively. The results showed that the response current changed synchronously with the 5-HT concentration, and the current values detected for the same concentration of 5-HT were very similar, indicating that the method of the present invention can realize multiple and stable repeated detection of 5-HT in the microfluidic-electrochemical sensor.
[0095] Fig.17 The figures are the DPV detection results (A) after allyl isothiocyanate (AITC) and cinnamaldehyde (CA) of the present invention stimulate QGP-1 cells to release 5-HT and the comparison of cell secretion 5-HT levels (B). Fig.17 Figure A shows the DPV test results of 5-HT secretion by QGP-1 cells stimulated by 0.3mmol / L AITC or 0.3mmol / L CA, and the control group is the DPV test diagram of cell supernatant (containing 0.3% DMSO) without stimulation drugs. The results show that the two drug stimulation groups (AITC or CA) enhanced the level of 5-HT released by QGP-1 cells to varying degrees (see Fig.17 In B), the TRPA1 agonist stimulates 5-HT release in a hierarchical order of AITC > CA. 2+ Increased influx is considered to be one of the main pathways for enterochromaffin cells to release 5-HT. Agonists induce the release of 5-HT and Ca 2+ influx, while AITC and CA induce Ca 2+In addition, studies have shown that 95% of the body's 5-HT is generated and released in the intestine, and then directly affects the balance of central neurotransmitters through the blood-brain barrier, or indirectly affects the central nervous system through the gut-brain axis, thereby causing neurological diseases such as epilepsy. Therefore, the microfluidic-electrochemical sensor constructed by the present invention detects the level of intestinal 5-HT release, which is helpful to predict epileptic seizures and monitor the progression of epilepsy.
Claims
1. A microfluidic-electrochemical sensor for continuous monitoring of the epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine, characterized in that: The method is prepared by the following steps: (1) modifying the surface of a screen-printed electrode with polypyrrole peroxide by electrochemical polymerization and cyclic voltammetry to obtain a screen-printed electrode modified with polypyrrole peroxide; (2) using an acrylic plate to accurately engrave a microfluidic device substrate; (3) assembling the screen-printed electrode modified with polypyrrole peroxide obtained in step (1) with the microfluidic device substrate obtained in step (2) by using double-sided tape and photocurable resin to prepare a microfluidic-electrochemical sensor; (4) using the prepared microfluidic-electrochemical sensor to detect the 5-hydroxytryptamine content by differential pulse voltammetry under a flow system; and (5) cleaning the microfluidic-electrochemical sensor electrode by a potential control method for the next 5-hydroxytryptamine detection by the microfluidic-electrochemical sensor.
2. A microfluidic-electrochemical sensor for continuous monitoring of epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine as claimed in claim 1, characterized in that: Applicable detection liquids for detecting 5-hydroxytryptamine 5-HT include phosphate buffer, human plasma and cell contact fluid. The 5-HT concentration range in phosphate buffer is 0.025 μmol / L~10 μmol / L, the 5-HT concentration range in 5wt% human plasma is 0.1 μmol / L~10 μmol / L, and the 5-HT concentration range in cell contact fluid is 0.05 μmol / L~10 μmol / L.
3. A microfluidic-electrochemical sensor for continuous monitoring of epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine as claimed in claim 1 or 2, characterized in that: According to the basic principle of capacitive deionization, the electrode interface cleaning technology based on potential regulation is adopted to realize the stable and continuous monitoring of 5-HT in fluid liquid by microfluidic-electrochemical sensor.
4. A microfluidic-electrochemical sensor for continuous monitoring of epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine as claimed in any one of claims 1 to 3, characterized in that: The entire process of liquid flow, signal detection and electrode cleaning in the microfluidic-electrochemical sensor is completely controlled by a peristaltic pump and an electrochemical workstation, and the neurotransmitter 5-hydroxytryptamine can be stably and continuously monitored.
5. A method for manufacturing a microfluidic-electrochemical sensor for continuously monitoring the epilepsy-related electroactive neurotransmitter 5-hydroxytryptamine as claimed in any one of claims 1 to 4, comprising the following steps in sequence: (1) Cleaning and pre-treating the screen-printed electrode SPCE with ultrapure water; (2) Constructing a polypyrrole (PPY) coating on the SPCE interface by electrochemical polymerization; (3) Preparation of peroxidized polypyrrole (OPPY) coating on the SPCE interface by electrochemical oxidation; (4) Design and manufacture microfluidic device substrates; (5) Assembling the peroxide polypyrrole modified screen-printed electrode OPPY / SPCE with the microfluidic device substrate to produce a microfluidic-electrochemical sensor; (6) Microfluidic-electrochemical sensor for detecting 5-hydroxytryptamine (5-HT) in flowing liquid; (7) The sensing interface of the microfluidic-electrochemical sensor is cleaned by a potential control method, and then the microfluidic-electrochemical sensor is used for the next 5-HT detection.
6. The detection operation method of the microfluidic-electrochemical sensor for continuously monitoring the electroactive neurotransmitter 5-hydroxytryptamine related to epilepsy as described in claim 5, characterized in that: The specific steps include: (1) Cleaning of screen-printed electrode SPCE: Clean SPCE three times with ultrapure water to remove adsorbed substances on the electrode surface, then dry with nitrogen and set aside; (2) Preparation of polypyrrole modified screen-printed electrode PPY / SPCE: The SPCE cleaned in step (1) was immersed in an aqueous solution containing 10 mmol / L pyrrole and 10 mmol / L poly(sodium 4-styrene sulfonate). The SPCE was scanned by cyclic voltammetry (CV) using a CHI660E electrochemical workstation. The scanning potential was 0-0.8 V and the scanning rate was 5 mV / s. The scanning was repeated for 5 cycles to obtain a polypyrrole modified screen-printed electrode PPY / SPCE. The SPCE was then washed with ultrapure water, dried with nitrogen gas, and set aside. (3) Preparation of peroxidized polypyrrole modified screen-printed electrode OPPY / SPCE: The OPPY / SPCE prepared in step (2) was immersed in a 0.5 mol / L NaOH solution, and the polypyrrole coating was peroxidized by the CV method. The scanning potential was 0-1 V, the scanning rate was 10 mV / s, and the scanning was repeated for 12 cycles to obtain a peroxidized polypyrrole modified screen-printed electrode OPPY / SPCE. The electrode was then washed with ultrapure water and set aside. (4) Preparation of microfluidic device substrate: Use WPS Office PowerPoint to draw the planar structure of the cover plate and flow channel plate of the microfluidic device substrate. According to the drawn pattern, use a laser engraving machine to carve out the hollow part on the acrylic plate to obtain the microfluidic device substrate; (5) Preparation of microfluidic-electrochemical sensor: The top surface of the flow channel of the microfluidic device substrate prepared in step (4) was adhered with a 0.2 mm thick PET transparent double-sided tape, and the double-sided tape at the liquid inlet and outlet was hollowed out, and the top surface was adhered to the cover plate, and the OPPY / SPCE prepared in step (3) was adhered to the detection area of the flow channel sheet with the OPPY modified interface facing the flow channel sheet, and the bottom surface was sealed with a 2 mm thick flexible strong tape, and the gap was filled with photocurable resin, and photocured under LED light for 120 s to prepare a microfluidic-electrochemical sensor; (6) Liquid flow system of microfluidic-electrochemical sensor: Use rubber tubes to connect the liquid inlet and liquid outlet of the microfluidic-electrochemical sensor prepared in step (5) to a peristaltic pump, and pump the test liquid into the microfluidic-electrochemical sensor at a flow rate of 50 μL / min to fill the microfluidic-electrochemical sensor; (7) Electrochemical detection of microfluidic-electrochemical sensor in flow system: After the test liquid filled the detection area, the peristaltic pump flow rate was maintained at 5 μL / min. After running for 20 min, 5-HT was detected by differential pulse voltammetry (DPV) using a CHI660E electrochemical workstation. The potential was -0.1 V to 0.6 V, the amplitude was 0.05 V, the pulse width was 0.05 s, the sampling width was 0.005 s, the pulse period was 0.2 s, and the DPV oxidation peak current value was recorded. (8) Cleaning of the microfluidic-electrochemical sensor: After the detection in step (7) is completed, PBS is pumped into the microfluidic chip from the cleaning solution injection port at a flow rate of 50 μL / min to clean the electrochemical detection area of the microfluidic-electrochemical sensor; the PBS flow rate is maintained at 50 μL / min, and the electrode interface is cleaned using potential control, that is, a chronoamperometric scan is used with the scanning potential set to 0.4 V and the scanning time set to 50 s. After the scan is completed, the peristaltic pump flow rate is increased to 500 μL / min to clean the electrode interface, and then the peristaltic pump speed is reduced to 50 μL / min for a second chronoamperometric scan with the scanning voltage set to −0.4 V and the scanning time set to 50 s. After the scan is completed, the liquid pumping from the cleaning solution injection port is stopped. The microfluidic-electrochemical sensor cleaned by the potential control method achieves regeneration of the electrode interface, and the above steps (6) and (7) are continued, which can be used for the next 5-HT detection.
7. The use of the microfluidic-electrochemical sensor for continuously monitoring the electroactive neurotransmitter 5-hydroxytryptamine related to epilepsy prepared by the method for preparing the microfluidic-electrochemical sensor for continuously monitoring the electroactive neurotransmitter 5-hydroxytryptamine related to epilepsy as claimed in claim 5, characterized in that: The 5-HT level released by human pancreatic cancer cells QGP-1 when stimulated by drugs was detected, and the 5-HT detection performance of the constructed microfluidic-electrochemical sensor in a cell culture environment was evaluated; the control model group was the 5-HT released by normal QGP-1 cells, and the drug intervention model group was the QGP-1 cells and the cell surface highly expressed transient receptor potential anchoring protein 1 channel TRPA1 agonist propyl isothiocyanate AITC or cinnamaldehyde CA, after which the 5-HT release of QGP-1 cells was stimulated and enhanced. The microfluidic-electrochemical sensor was used to detect the level of 5-HT released by cells in the control model group and the propyl isothiocyanate AITC or cinnamaldehyde CA drug intervention group; the results showed that AITC or CA in the two drug stimulation groups enhanced the level of 5-HT released by QGP-1 cells to varying degrees, and the hierarchical efficacy of TRPA1 agonist stimulating 5-HT release was AITC>CA; the above results all prove that microfluidic-electrochemical sensors can be used for the detection of epilepsy-related electroactive neurotransmitter 5-HT.
Citation Information
Patent Citations
Electrochemistry on-line cleaning method for heavy metal on-line monitor working electrode
CN102608191A
Electrochemical immunosensing method for detecting Listeria monocytogenes
CN104634847A
Renewable electrochemical sensor for simultaneously detecting epinephrine and uric acid, and preparation method and application thereof
CN111474222A
Multi-target heavy metal microfluidic electrochemical sensor and preparation and application thereof
CN112763555A
High-sensitivity and high-selectivity sweat collection and detection electrochemical sensor and preparation method thereof
CN116337964A
